Loading...
Bristol Myers Squibb (BMY): Undervalued Opportunity or Value Trap? A Deep Dive into 2024 Earnings and Fair Value
Evangelos's Fair Value
US$65.00
32.1% undervalued intrinsic discount25 Feb
US$44.15
1Y
-14.7%7D
-1.8%1Y
-14.7%7D
-1.8%You can edit this narrative until May 14 2:38 AM. Then, changes will post as Updates.